ロード中...
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody
OBJECTIVE: We evaluated the expression of human trophoblast cell-surface marker (Trop-2) and the potential of hRS7, a humanized monoclonal anti-Trop-2 antibody, as a therapeutic agent against chemotherapy-resistant ovarian disease. METHODS: Trop-2 expression was evaluated by immunohistochemistry (IH...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3104081/ https://ncbi.nlm.nih.gov/pubmed/21453957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.03.002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|